FDA.reportPublic FDA data

phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]

RxCUI
2677798
RxNorm name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Display name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Full name
phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
96bb1e53-c2cc-4e60-a21a-db0269c371bfRyzumvi 0.75 % Ophthalmic Solution [PSN] · phentolamine 7.5 MG/ML Ophthalmic Solution [Ryzumvi] [SBD] · Ryzumvi 7.5 MG (as phentolamine mesylate 10 MG) per 1 ML Ophthalmic Solution [SY]34These highlights do not include all the information needed to use RYZUMVI safely and effectively. See full prescribing information for RYZUMVI. RYZUMVI™ (phentolamine ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 195220240531